Clinical Trials on Systemic Inflammatory Response Syndrome (SIRS) in Japan

Total 435 results

Wakayama Medical University
Osaka City University; Tohoku University; Hyogo College of Medicine; Osaka City... and other collaborators

Completed

Dexmedetomidine for Sepsis in ICU Randomized Evaluation Trial (DESIRE)

Sepsis

Japan
Kyoto University
Pfizer; Astellas Pharma Inc

Withdrawn

Fluconazole Versus Micafungin for Candida Bloodstream Infection in Non-Neutropenic Patients

Sepsis | Candidiasis

Japan
Takeda

Terminated

Efficacy and Safety of Resatorvid in Patients With Sepsis-induced Cardiovascular and Respiratory Failure

Sepsis

Japan
Bayer

Active, not recruiting

An Observational Study to Learn About the Occurrence of Disseminated Intravascular Coagulation Among Adults With Sepsis in Japan

Sepsis | Disseminated Intravascular Coagulation

Japan
AstraZeneca

Completed

A Study to Assess Safety,and Tolerability of 2 Doses of AZD9773 (CytoFab™) in Japanese With Severe Sepsis/Septic Shock

Septic Shock | Severe Sepsis

Japan
Ono Pharmaceutical Co. Ltd

Completed

Study of Sivelestat Sodium Hydrate in Acute Lung Injury (ALI) Associated With Systemic Inflammatory Response Syndrome (SIRS) in Japan

Systemic Inflammatory Response Syndrome | Acute Lung Injury

Japan
Eisai Inc.

Completed

ACCESS: A Controlled Comparison of Eritoran Tetrasodium and Placebo in Patients With Severe Sepsis

Severe Sepsis

United States, France, Poland, United Kingdom, Germany, Hong Kong, Taiwan, Spain, Switzerland, Argentina, Belgium, Israel, South Africa, Japan, Canada, Netherlands, Korea, Republic of, Australia, Chile, Brazil, Austria, Italy, Czechia, Portug...
Jerry Zimmerman
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Recruiting

Stress Hydrocortisone In Pediatric Septic Shock (SHIPSS)

Septic Shock

United States, Canada, China, Israel, Japan, Malaysia, Pakistan, Vietnam, Singapore, Saudi Arabia
Takeda

Completed

Efficacy & Safety of Resatorvid in Adults With Severe Sepsis

Sepsis

United States, United Kingdom, Belgium, Germany, Spain, Israel, Japan, Australia, Canada, Finland, Netherlands, New Zealand, Czech Republic, Puerto Rico, Austria, Sweden, Italy
SymBio Pharmaceuticals

Recruiting

Study to Confirm of the Safety and Tolerability of Brincidofovir in Subjects With BK Virus Infection (Viremia) After Kidney Transplantation

BK Virus Infection | Kidney Transplantation | Nephropathy

Australia, Japan
Merck Sharp & Dohme LLC

Completed

Safety, Efficacy, and Pharmacokinetics (PK) of Daptomycin (MK-3009) in Japanese Pediatric Subjects With Complicated Skin and Soft Tissue Infections (cSSTI) and Bacteremia (MK-3009-029)

Skin Diseases, Infectious | Bacteremia | Soft Tissue Infections

Japan
Takeda

Recruiting

A Study of Teduglutide in Japanese People With Short Bowel Syndrome

Short Bowel Syndrome

Japan
Eisai Co., Ltd.

Completed

Post-marketing Surveillance of Long-term Administration of Inovelon Tablets in Patients With Lennox-Gastaut Syndrome

Lennox-Gastaut Syndrome

Japan
Novartis Pharmaceuticals

Completed

Efficacy and Safety Study of Canakinumab Administered for 6 Months (24 Weeks) in Japanese Patients With Cryopyrin-associated Periodic Syndromes Followed by an Extension Phase

Familial Cold Autoinflammatory Syndrome | Muckle-Wells Syndrome | Neonatal Onset Multisystem Inflammatory Disease | Cryopyrin-associated Periodic Syndromes

Japan
Nihon Pharmaceutical Co., Ltd

Completed

Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Chronic Inflammatory Demyelinating Polyneuropathy.

Chronic Inflammatory Demyelinating Polyneuropathy

Japan
Rohto Pharmaceutical Co., Ltd.

Completed

An Exploratory Study of ADR-001 in Patients With Severe Pneumonia Caused by SARS-CoV-2 Infection (COVID-19)

Severe Acute Respiratory Syndrome Coronavirus 2

Japan
Chikara Tashiro

Completed

Risk of Methicillin-resistant S.Aureus (MRSA) Infections in MRSA Carrier Under Introduction of Rapid MRSA Screening

Inflammatory Bowel Disease | Pancreas Disease | Hepatobiliary Disease

Japan
Nagoya University
Japan Agency for Medical Research and Development; Zenyaku Kogyo Co., Ltd.

Completed

The Evaluation of Efficacy and Safety of Rituximab in Refractory CIDP Patients With IgG4 Autoantibodies (RECIPE)

Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

Japan
Nagoya University

Unknown

Improvement in Baroreflex Sensitivity in OSAS

Obstructive Sleep Apnea Syndrome

Japan
Keio University

Unknown

Confocal Microscopy and Lacrimal Gland in Sjogren's Syndrome

Primary Sjogren's Syndrome

Japan
Tokyo Medical University

Recruiting

Median Nerve Strain and Applied Pressure Measurement in the Carpal Tunnel Syndrome Patients

Carpal Tunnel Syndrome

Japan
Takeda

Recruiting

Specified Drug-Use Survey on Vedolizumab for IV Infusion 300 mg [Crohn's Disease]

Crohn's Disease

Japan
Takeda

Completed

A Study of TAK-019 in Healthy Japanese Adults (COVID-19)

Prevention of Infection Disease Caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

Exploratory Study for Dry Mouth in Patients With Sjögren's Syndrome

Sjogren's Syndrome | Xerostomia

Japan
Takeda
Takeda

Completed

An Extension Study of Teduglutide in Japanese Participants With Short Bowel Syndrome Who Completed 24 Weeks of Treatment in SHP633-306 or TED-C14-004

Short Bowel Syndrome

Japan
Shire

Completed

Study of Teduglutide in Japanese Participants With Short Bowel Syndrome

Short Bowel Syndrome

Japan
Mitsubishi Tanabe Pharma Corporation

Completed

Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety Study of MT-1303 in Subjects With Crohn's Disease

Crohn's Disease

Japan
Tokyo Medical and Dental University

Active, not recruiting

Therapeutic Optimization Study Based on MR Enterocolonography in Patients With Crohn's Disease

Crohn Disease

Japan
Takeda

Completed

A Study of Teduglutide in Japanese Children With Short Bowel Syndrome Aged 4 Months or Older

Short Bowel Syndrome

Japan
Shire

Completed

Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Teduglutide in Japanese Subjects With PN-dependent Short Bowel Syndrome (SBS)

Short Bowel Syndrome

Japan
Takeda

Recruiting

A Survey of Darvadstrocel in People With Crohn's Disease (J-INSPIRE)

Crohn's Disease

Japan
Kissei Pharmaceutical Co., Ltd.

Terminated

An Extension Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome

Dry Eye With Sjögren's Syndrome

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

A Long-term Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome

Dry Eye With Sjögren's Syndrome

Japan
Nihon Pharmaceutical Co., Ltd

Completed

Phase III Clinical Trial of NPB-01 in Patients With Guillain-Barré Syndrome

Guillain-Barré Syndrome

Japan
Mitsubishi Tanabe Pharma Corporation

Completed

Efficacy and Safety of Increased Dose of TA-650 (Infliximab) in Patients With Crohn's Disease (CD)

Crohn's Disease

Japan
Kyoto University, Graduate School of Medicine

Completed

The Roles of Prostanoids in Patients With Sleep Apnea Syndrome

Sleep Apnea

Japan
Novartis Pharmaceuticals

Completed

Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome

Cushing's Syndrome | Ectopic Corticotropin Syndrome | Adrenal Adenoma | Adrenal Carcinoma | AIMAH | PPNAD

Japan
Japan Blood Products Organization

Completed

Efficacy and Safety Study of GB-0998 for Guillain-Barré Syndrome

Guillain-Barré Syndrome

Japan
Pfizer

Completed

Xeljanz Special Investigation for Long-term Use in UC Patients

Ulcerative Colitis

Japan
Takeda

Active, not recruiting

Specified Drug-Use Survey on Vedolizumab for IV Infusion 300 mg [Ulcerative Colitis]

Ulcerative Colitis

Japan
Kyoto University, Graduate School of Medicine
National Institute of Biomedical Innovation

Terminated

Therapeutic Study of ONO-4819CD for Ulcerative Colitis

Ulcerative Colitis

Japan
Ferring Pharmaceuticals

Completed

A Study of Terlipressin in Patients With Hepatorenal Syndrome Type 1 (HRS)

Hepatorenal Syndrome Type 1

Japan
Kissei Pharmaceutical Co., Ltd.

Recruiting

An Early Phase 2 Clinical Study of KSP-0243

Colitis, Ulcerative

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

A Phase III Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome

Dry Eye With Sjögren's Syndrome

Japan
Celgene

Completed

A Study of Special Use Results Surveillance of Revlimid 5mg Capsules

Myelodysplastic Syndromes | Multiple Myeloma

Japan
Tohoku University

Unknown

Effect of Bifidobacterium on Irritable Bowel Syndrome (PBIBS)

Irritable Bowel Syndrome

Japan
Pfizer

Completed

Infliximab Biosimilar "Pfizer" Drug Use Investigation (Crohn's Disease or Ulcerative Colitis)

Crohn's Disease | Ulcerative Colitis

Japan
Showa Inan General Hospital

Recruiting

Association Between LRG and Histologic Remission in Ulcerative Colitis

Ulcerative Colitis in Histologic Remission

Japan
AM-Pharma

Terminated

(Revival) Study to Investigate the Efficacy and Safety of Alkaline Phosphatase in Patients With Sepsis-Associated AKI

Acute Kidney Injury Due to Sepsis

Belgium, Spain, United States, Austria, Denmark, France, United Kingdom, Finland, New Zealand, Australia, Germany, Canada, Netherlands, Ireland, Japan
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Pharmacokinetics of Raltegravir (MK-0518) in Healthy Japanese Male Participants (MK-0518-851)

Human Immunodeficiency Virus (HIV) Infection

Japan

Clinical Trials on Systemic Inflammatory Response Syndrome (SIRS) in Japan

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Dominican Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations